Showing results (1871-1880 of 2,276) with videos related to
Sort By:
Pageof 228
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2017
Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression StatusTsuyoshi Hamada, Yin Cao, Zhi Rong Qian, et al.Nature Medicine|May 31, 2020
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinomaDavid A Braun, Yue Hou, Ziad Bakouny, et al.Heart (British Cardiac Society)|September 20, 2019
Maternal and neonatal outcomes in women with history of coronary artery diseaseMatthew Cauldwell, Philip J Steer, Katherine von Klemperer, et al.Proceedings of the National Academy of Sciences of the United States of America|February 1, 2023
Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse modelsMeenal Datta, Sampurna Chatterjee, Elizabeth M Perez, et al.Science Advances|March 14, 2018
Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesiclesFranz L Ricklefs, Quazim Alayo, Harald Krenzlin, et al.Science (New York, N.Y.)|April 13, 2023
The evolution of hominoid locomotor versatility: Evidence from Moroto, a 21 Ma site in UgandaLaura M MacLatchy, Susanne M Cote, Alan L Deino, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2020
Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in GlioblastomaJ Bryan Iorgulescu, Prafulla C Gokhale, Maria C Speranza, et al.Cancer Discovery|October 1, 2013
Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumorsEsra A Akbay, Shohei Koyama, Julian Carretero, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2026
Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear Cell Renal Cell Carcinoma: analyses of the HCRN GU16-260 trialNourhan El Ahmar, Morgan A Paul, Berkay Simsek, et al.Nature|November 28, 2014
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigensMatthew M Gubin, Xiuli Zhang, Heiko Schuster, et al.Pageof 228